Eurobio Scientific Société anonyme
EPA:ALERS.PA
24.95 (EUR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 130.003 | 152.607 | 184.712 | 188.856 | 59.475 | 51.071 | 42.78 | 27.825 | 29.78 | 31.044 | 31.216 | 5.387 | 4.993 | 8.171 | 4.892 | 4.219 | 5.385 |
| Cost of Revenue
| 76.68 | 87.564 | 87.269 | 83.246 | 41.129 | 33.482 | 29.822 | 23.014 | 25.089 | 23.061 | 23.563 | 0.449 | 0 | 0 | 8.984 | 9.878 | 8.609 |
| Gross Profit
| 53.323 | 65.043 | 97.443 | 105.61 | 18.346 | 17.589 | 12.958 | 4.811 | 4.691 | 7.983 | 7.653 | 4.938 | 4.993 | 8.171 | -4.092 | -5.659 | -3.224 |
| Gross Profit Ratio
| 0.41 | 0.426 | 0.528 | 0.559 | 0.308 | 0.344 | 0.303 | 0.173 | 0.158 | 0.257 | 0.245 | 0.917 | 1 | 1 | -0.836 | -1.341 | -0.599 |
| Reseach & Development Expenses
| 5.262 | 3.173 | 2.827 | 1.897 | 1.637 | 1.421 | 2.107 | 3.161 | 3.965 | 5.642 | 7.346 | 6.983 | 7.717 | 8.48 | 8.984 | 0 | 0 |
| General & Administrative Expenses
| 14.273 | 11.397 | 7.419 | 6.213 | 4 | 5.308 | 5.455 | 4.168 | 4.555 | 4.935 | 6.495 | 3.531 | 3.863 | 5.578 | 4.329 | 4.592 | 3.521 |
| Selling & Marketing Expenses
| 19.249 | 19.603 | 17.08 | 16.29 | 10.94 | 10.652 | 11.471 | 8.333 | 8.583 | 9.099 | 7.932 | 0.898 | 1.508 | 1.334 | 1.239 | 1.144 | 1.049 |
| SG&A
| 33.522 | 31 | 24.499 | 22.503 | 14.94 | 15.96 | 16.926 | 12.501 | 13.138 | 14.034 | 14.427 | 4.429 | 5.371 | 6.912 | 5.568 | 5.736 | 4.57 |
| Other Expenses
| -4.398 | 0.168 | 1.87 | 0 | 0 | 0 | 0 | 0 | 0 | -0.104 | -0.021 | -0.305 | -0.491 | -0.247 | 0 | 0 | 0 |
| Operating Expenses
| 43.182 | 34.005 | 25.456 | 24.4 | 17.486 | 19.394 | 21.571 | 12.841 | 10.808 | 14.196 | 14.735 | 11.483 | 13.088 | 15.145 | 5.568 | 5.736 | 4.57 |
| Operating Income
| 10.141 | 31.038 | 71.987 | 81.21 | 0.569 | -1.159 | -5.785 | -7.39 | -8.342 | -5.687 | -7.024 | -6.474 | -8.095 | -6.974 | -9.659 | -11.394 | -7.794 |
| Operating Income Ratio
| 0.078 | 0.203 | 0.39 | 0.43 | 0.01 | -0.023 | -0.135 | -0.266 | -0.28 | -0.183 | -0.225 | -1.202 | -1.621 | -0.854 | -1.974 | -2.701 | -1.447 |
| Total Other Income Expenses Net
| -3.164 | -1.355 | -0.675 | -0.322 | -0.406 | -1.66 | -3.493 | -0.862 | 1.867 | -0.776 | -0.107 | -0.474 | -0.107 | -2.103 | 0.343 | 0.38 | -0.221 |
| Income Before Tax
| 6.977 | 29.683 | 71.312 | 80.888 | 0.163 | -2.819 | -9.278 | -8.252 | -6.475 | -6.463 | -7.131 | -6.713 | -8.202 | -9.077 | -9.317 | -11.015 | -8.015 |
| Income Before Tax Ratio
| 0.054 | 0.195 | 0.386 | 0.428 | 0.003 | -0.055 | -0.217 | -0.297 | -0.217 | -0.208 | -0.228 | -1.246 | -1.643 | -1.111 | -1.905 | -2.611 | -1.488 |
| Income Tax Expense
| 2.142 | 4.746 | 10.768 | 7.407 | 2.99 | 0.051 | 0.691 | 0.52 | 0.6 | 0.98 | 1.137 | -0.943 | -1.103 | -1.329 | -1.616 | -2.089 | -0.675 |
| Net Income
| 4.835 | 24.937 | 60.544 | 73.481 | 3.153 | -2.768 | -9.969 | -7.733 | -5.879 | -5.487 | -5.994 | -5.77 | -7.099 | -7.748 | -7.701 | -8.925 | -7.34 |
| Net Income Ratio
| 0.037 | 0.163 | 0.328 | 0.389 | 0.053 | -0.054 | -0.233 | -0.278 | -0.197 | -0.177 | -0.192 | -1.071 | -1.422 | -0.948 | -1.574 | -2.115 | -1.363 |
| EPS
| 0.43 | 2.44 | 5.58 | 6.56 | 0.29 | -0.28 | -1.14 | -1.98 | -1.66 | -1.77 | -2.11 | -3.21 | -2.11 | -4.68 | -5.47 | -6.67 | -5.74 |
| EPS Diluted
| 0.43 | 2.43 | 5.57 | 6.53 | 0.28 | -0.28 | -1.14 | -1.98 | -1.66 | -1.77 | -2.11 | -3.21 | -2.11 | -4.68 | -5.47 | -6.67 | -5.74 |
| EBITDA
| 23.286 | 40.559 | 79.852 | 88.223 | 6.938 | 2.248 | 0.098 | -4.954 | -6.069 | -3.361 | -4.659 | -6.381 | -7.329 | -6.267 | -8.901 | -10.934 | -7.258 |
| EBITDA Ratio
| 0.179 | 0.266 | 0.432 | 0.467 | 0.117 | 0.044 | 0.002 | -0.178 | -0.204 | -0.108 | -0.149 | -1.185 | -1.468 | -0.767 | -1.82 | -2.592 | -1.348 |